logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Luis de la Cruz‐Merino

university health network toronto

43H-index
345Paper Count
1.5WCitation Count
Published Papers 102
Publication Date
logo
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
errESMO Open
IF8.3
err2025-11-25
err0
errOAAI
errS. Kuemmel; K.H. Jung; L. Andrade; D. Assad-Suzuki; L. de la Cruz Merino; R. Freitas-Junior; R. Hegg; C.-S. Huang; H. Martin; A. Schneeweiss; M. Dieterich; A. Nguyen Duc; Y. Feng; R. Meng; A. Swat; A. Seiller; B. Bermejo; E.P. Hamilton
errShare
errSave
Emerging Role of MDSCS as Novel Biomarkers and Therapeutic Targets for Cancer Immunotherapy
errImmunoTargets and Therapy
IF4.4
err2025-11-10
err0
errOAAI
errS Silva-Romeiro; Rocio del Carmen Flores-Campos; María Luisa Sánchez-León; V Sánchez-Margalet; Luis De la Cruz-Merino
errShare
errSave
Chronic granulomatous herpes simplex encephalitis in a child with digeorge syndrome- expanding the spectrum of herpes-associated neurological disease
errBMC Infectious Diseases
IF3
err2025-10-03
err0
errOAAI
errDeepti Ashok Kewalramani; Yathwin Kanagavel; Visvanathan Krishnaswamy; Latha Ravichandran; Lawrence D. Cruz; Padmasani Venkat Ramanan; Ram Mohan; Dr. Ranjith Kumar Manokaran
errShare
errSave
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err5
PREAI
errAscierto, Paolo A.; Del Vecchio, Michele; Merelli, Barbara; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, Charles Lance; Schenker, Michael; Gaudy-Marqueste, Caroline; Pigozzo, Jacopo; Marquez-Rodas, Ivan; Butler, Marcus O.; Di Giacomo, Anna Maria; Gligich, Oleg; de la Cruz-merino, Luis; Arenberger, Petr; Atkinson, Victoria; Nathan, Paul; Hill, Andrew; Millward, Michael; Fecher, Leslie A.; Khushalani, Nikhil I.; Queirolo, Paola; Soomro, Raheela; Rathod, Dhanrajsinh; Askelson, Margarita; Pe Benito, Melanie; Joseph, Devanand; Larkin, James
errShare
errSave
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
errNature Cancer
IF28.5
err2025-07-23
err0
PREAI
errGiulia Petroni; Claudia Galassi; Kenneth H. Gouin; Hsiang-Han Chen; Aitziber Buqué; Norma Bloy; Takahiro Yamazaki; Ai Sato; Manuel Beltrán-Visiedo; Ginevra Campia; Carlos Jiménez-Cortegana; Aagam Shah; Alexander Kirchmair; Chiara Massa; Claudia Wickenhauser; Carlos Eduardo de Andrea; Belén Navarro-Rubio; Irantzu Serrano-Mendioroz; Esther Navarro Manzano; Alexandra M. Satty; Brady Rippon; Francesca Finotello; Zlatko Trajanoski; Xi Kathy Zhou; Joseph M. Scandura; Elena García-Martínez; Francisco Ayala de la Peña; María Esperanza Rodríguez-Ruiz; Barbara Seliger; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Reva K. Basho; Stephen L. Shiao; Heather L. McArthur; Silvia C. Formenti; Simon R. V. Knott; Lorenzo Galluzzi
errShare
errSave
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
errNature Cancer
IF28.5
err2025-07-07
err0
PREAI
errGiulia Petroni; Claudia Galassi; Kenneth H. Gouin; Hsiang-Han Chen; Aitziber Buqué; Norma Bloy; Takahiro Yamazaki; Ai Sato; Manuel Beltrán-Visiedo; Ginevra Campia; Carlos Jiménez-Cortegana; Aagam Shah; Alexander Kirchmair; Chiara Massa; Claudia Wickenhauser; Carlos Eduardo de Andrea; Belén Navarro-Rubio; Irantzu Serrano-Mendioroz; Esther Navarro Manzano; Alexandra M. Satty; Brady Rippon; Francesca Finotello; Zlatko Trajanoski; Xi Kathy Zhou; Joseph M. Scandura; Elena García-Martínez; Francisco Ayala de la Peña; María Esperanza Rodríguez-Ruiz; Barbara Seliger; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Reva K. Basho; Stephen L. Shiao; Heather L. McArthur; Silvia C. Formenti; Simon R. V. Knott; Lorenzo Galluzzi
errShare
errSave
Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2025-05-08
err0
errOAAI
errSanchez-Camacho, Alberto; Torres-Zurita, Alberto; Gallego-Lopez, Laura; Hernandez-Pacheco, Rocio; Silva-Romeiro, Silvia; de la Gala, Maria del Carmen Alamo; de Ceballos, Enrique Enrique Peral-Gutierrez; de la Cruz-merino, Luis
errShare
errSave
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
errFUTURE ONCOLOGY
IF2.6
err2025-05-08
err0
PREAI
errGarcia-Foncillas, Jesus; Bayle, Arnaud; Arnold, Dirk; Avouac, Bernard; Awada, Ahmad; de la Cruz-merino, Luis; Helland, Aslaug; Lassen, Ulrik; Laurent-Puig, Pierre; Normanno, Nicola; Rohrberg, Kristoffer; Taieb, Julien; Stenzinger, Albrecht
errShare
errSave
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific
errCELL REPORTS MEDICINE
IF10.6
err2025-04-01
err0
errOAAI
errSacco, Joseph J.; Kirk, Peter; Leach, Emma; Shoushtari, Alexander N.; Carvajal, Richard D.; Britton-Rivet, Camille; Khakoo, Sophie; Collins, Laura; de la Cruz-Merino, Luis; Eroglu, Zeynep; Ikeguchi, Alexandra P.; Nathan, Paul; Hamid, Omid; Butler, Marcus O.; Stanhope, Sarah; Ranade, Koustubh; Sato, Takami
errShare
errSave
Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8+cells and vitamin D
errCANCER & METABOLISM
IF5.3
err2025-03-04
err0
errOAAI
errHontecillas-Prieto, Lourdes; Garcia-Dominguez, Daniel J.; Jimenez-Cortegana, Carlos; Nogales-Fernandez, Esteban; Palazon-Carrion, Natalia; Garcia-Sancho, Alejandro Martin; Rios-Herranz, Eduardo; Guma-Padro, Josep; Provencio-Pulla, Mariano; Rueda-Dominguez, Antonio; de la Cruz-merino, Luis; Sanchez-Margalet, Victor
errShare
errSave
Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2025-02-01
err0
PREAI
errYoon, Charles H.; Ross, Merrick I.; Gastman, Brian R.; Luke, Jason J.; Ascierto, Paolo A.; Long, Georgina V.; Rutkowski, Piotr; Khattak, Muhammad; Del Vecchio, Michele; de la Cruz Merino, Luis; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Schadendorf, Dirk; Carlino, Matteo S.; Zhao, Yujie; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M. M.; Gershenwald, Jeffrey E.; Sondak, Vernon K.
errShare
errSave
Role of Sam68 in different types of cancer (Review)
errINTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
IF5.8
err2024-10-22
err0
PREAI
errJimenez-Cortegana, Carlos; Sanchez-Jimenez, Flora; De La Cruz-Merino, Luis; Sanchez-Margalet, Victor
errShare
errSave
Pembrolizumab (pembro) vs placebo as adjuvant therapy for high-risk stage II melanoma: Long-term follow-up, rechallenge, and crossover in KEYNOTE-716
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err2
PREAI
errLuke, J. J.; Ascierto, P. A.; Khattak, M. A.; Rutkowski, P.; Del Vecchio, M.; Spagnolo, F.; Mackiewicz, J.; de la Cruz Merino, L.; Sileni, V. Chiarion; Kirkwood, J. M.; Robert, C.; Schadendorf, D.; De Galitiis, F.; Carlino, M. S.; Odeleye-Ajakaye, A.; Kalabis, M.; Krepler, C.; Eggermont, A. M. M.; Long, G. V.
errShare
errSave
Sitravatinib plus tislelizumab for metastatic uveal melanoma with liver metastasis: The open-label, multicenter, phase II GEM-2101 trial
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errde Carpio Huerta, L. P.; Espinosa, E.; de la Cruz Merino, L.; Berrocal-Jaime, A.; Piulats, J. M.
errShare
errSave
Technical considerations for isolated limb perfusion: A consensus paper
errEJSO
IF2.9
err2024-06-01
err6
PREAI
errHayes, Andrew J.; Coker, David J.; Been, Lukas; Boecxstaens, Veerle WSM.; Bonvalot, Sylvie; De Cian, Franco; Cruz-Merino, Luis de la; Duarte, Carlos; Eggermont, Alexander; Farricha, Victor; Fiore, Marco; Gruenhagen, Dirk; Gruetzmann, Robert; Honore, Charles; Jakob, Jens; Hocevar, Marko; van Houdt, Winan; Klauzner, Joseph; Kettelhack, Christoph; Marten, Angela; Martinez-Said, Hector; Matter, Maurice; Michot, Audrey; Niethard, Maya; Pennacchioli, Elisabetta; Podleska, Lars E.; Rabago, Gregorio; Rastrelli, Marco; Reijers, Sophie; Ribeiro, Matilde; Schwarzbach, Matthias; Snow, Hayden A.; Spacek, Miroslav; Stoldt, Stephan; Testori, Alessandro; Zoras, Odysseas; Bagge, Roger Olofsson
errShare
errSave
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2024-03-13
err1
errOAAI
errSchadendorf, Dirk; Luke, Jason John; Ascierto, Paolo A.; Long, Georgina, V; Rutkowski, Piotr; Khattak, Adnan; Del Vecchio, Michele; de la Cruz-Merino, Luis; Mackiewicz, Jacek; Sileni, Vanna Chiarion; Kirkwood, John M.; Robert, Caroline; Grob, Jean-Jacques; Dummer, Reinhard; Carlino, Matteo S.; Zhao, Yujie; Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander; Scolyer, Richard A.
errShare
errSave
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
errANNALS OF ONCOLOGY
IF65.4
err2024-03-01
err6
errOAAI
errPiulats, J. M.; Watkins, C.; Costa-Garcia, M.; del Carpio, L.; Piperno-Neumann, S.; Rutkowski, P.; Hassel, J. C.; Espinosa, E.; de la Cruz-Merino, L.; Ochsenreither, S.; Shoushtari, A. N.; Orloff, M.; Salama, A. K. S.; Goodall, H. M.; Baurain, J. -F.; Nathan, P.
errShare
errSave
CD8+NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2024-02-26
err3
errOAAI
errHontecillas-Prieto, Lourdes; Garcia-Dominguez, Daniel J.; Palazon-Carrion, Natalia; Garcia-Sancho, Alejandro Martin; Nogales-Fernandez, Esteban; Jimenez-Cortegana, Carlos; Sanchez-Leon, Maria L.; Silva-Romeiro, Silvia; Flores-Campos, Rocio; Carnicero-Gonzalez, Fernando; Rios-Herranz, Eduardo; de la Cruz-Vicente, Fatima; Rodriguez-Garcia, Guillermo; Fernandez-Alvarez, Ruben; Martinez-Banaclocha, Natividad; Guma-Padro, Josep; Gomez-Codina, Jose; Salar-Silvestre, Antonio; Rodriguez-Abreu, Delvys; Galvez-Carvajal, Laura; Labrador, Jorge; Guirado-Risueno, Maria; Provencio-Pulla, Mariano; Sanchez-Beato, Margarita; Marylene, Lejeune; Alvaro-Naranjo, Tomas; Casanova-Espinosa, Maria; Rueda-Dominguez, Antonio; Sanchez-Margalet, Victor; de la Cruz-Merino, Luis
errShare
errSave
Dendritic cells: the yin and yang in disease progression
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2024-01-04
err5
errOAAI
errJimenez-Cortegana, Carlos; Palomares, Francisca; Alba, Gonzalo; Santa-Maria, Consuelo; de la Cruz-merino, Luis; Sanchez-Margalet, Victor; Lopez-Enriquez, Soledad
errShare
errSave
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2023-11-14
err0
errOAAI
errJimenez-Cortegana, Carlos; Salamanca, Elena; Palazon-Carrion, Natalia; Sanchez-Jimenez, Flora; Perez-Perez, Antonio; Vilarino-Garcia, Teresa; Fuentes, Sandra; Martin, Salomon; Jimenez, Marta; Galvan, Raquel; Rodriguez-Chacon, Carmen; Sanchez-Mora, Catalina; Moreno-Mellado, Elisa; Gutierrez-Gutierrez, Belen; Alvarez, Nerissa; Sosa, Alberto; Garnacho-Montero, Jose; de la Cruz-merino, Luis; Rodriguez-Bano, Jesus; Sanchez-Margalet, Victor
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
Dirk Schadendorf
H-index: 182 · Papers: 2.4K
G
Georgina V. Long
H-index: 169 · Papers: 1.8K
A
Antoni Ribas
H-index: 158 · Papers: 1.7K
C
Caroline Robert
H-index: 154 · Papers: 1.5K
R
Reinhard Dummer
H-index: 152 · Papers: 2.8K
View more